Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...

Sepehr Shojaei, VP of Design Solutions at Lightship, talks about how the company works with pharma and contract research ...

The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...

With an increased need for operational efficiency, while also leveraging new technologies such as AI, the landscape of ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, ...

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials ...

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials ...

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, Edetek, discusses how Edetek's R&D cloud system addresses challenges in ...

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials ...

Regulatory Considerations when Designing and Running 21st Century Paperless Clinical Trials ...

The long-held practice is effective in pinpointing the emergence of known and unknown risks to clinical development, study ...